Oncologic Benefit of Adjuvant Therapy in Lateral Pelvic Lymph Node Metastasis following Neoadjuvant Chemoradiotherapy and Lateral Pelvic Lymph Node Dissection

Background: It remains controversial whether the addition of adjuvant chemotherapy (ACT) to total mesorectal excision (TME) plus lateral pelvic lymph node dissection (LLND) can provide a survival benefit after neoadjuvant chemoradiotherapy (nCRT) in patients with clinically suspected lateral pelvic...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yu-Juan, Zhou, Si-Cheng, Chen, Jing-Hua, Liang, Jian-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608212/
https://www.ncbi.nlm.nih.gov/pubmed/36313037
http://dx.doi.org/10.7150/jca.77689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608212/
https://www.ncbi.nlm.nih.gov/pubmed/36313037
http://dx.doi.org/10.7150/jca.77689

Ejemplares similares